[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

Division of Medical Imaging and Hematology Products Presentations

2006

  • FDA Staff Presentations at the Annual Society of Nuclear Medicine Meeting

    • Imaging Submissions to FDA: Consultative review process [PDF], Tiffany Brown, M.P.H.

    • Imaging Biomarkers and Imaging Standardization [PDF], Alexander Gorovets, M.D.

    • Highlights of Standard Meetings with the Medical Imaging Division [PDF], Kyong “Kaye” Kang, Pharm.D.

    • Chemistry, Manufacturing and Controls (CMC) for PET Drug Products [PDF], Ravindra K. Kasliwal, Ph.D.

    • Exploratory IND Studies: Pre-clinical Requirements [PDF], Tushar Kokate, Ph.D.

    • Implementation of the Exploratory IND: Medical Imaging Division Reorganization [PDF], George Mills, M.D., M.B.A.

    • The Administrative Process of Submitting Positron Emission Tomography (PET) Drug Applications [PDF], Thuy Nguyen, M.P.H.

    • The Radioactive Drug Research Committee (RDRC): A 2006 Update [PDF], Orhan H. Suleiman MS, PhD, FAAPM

    • The Study of Radioactive Drugs in Human Subjects: Radioactive Drug Research Committee (RDRC) versus Investigational New Drug (IND) [PDF], Renee Tyson

PDF requires the free Adobe Acrobat Reader

    Back to Top   Back to RDRC Information

Date created: July 7, 2006
horizonal rule

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA/Center for Drug Evaluation and Research